Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Pitfalls of intranasal naloxone.

Zuckerman M, Weisberg SN, Boyer EW.

Prehosp Emerg Care. 2014 Oct-Dec;18(4):550-4. doi: 10.3109/10903127.2014.896961. Epub 2014 May 15.

2.

Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose.

Robertson TM, Hendey GW, Stroh G, Shalit M.

Prehosp Emerg Care. 2009 Oct-Dec;13(4):512-5. doi: 10.1080/10903120903144866.

PMID:
19731165
3.

Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.

Kerr D, Kelly AM, Dietze P, Jolley D, Barger B.

Addiction. 2009 Dec;104(12):2067-74. doi: 10.1111/j.1360-0443.2009.02724.x.

PMID:
19922572
4.

Prehospital Naloxone Administration as a Public Health Surveillance Tool: A Retrospective Validation Study.

Lindstrom HA, Clemency BM, Snyder R, Consiglio JD, May PR, Moscati RM.

Prehosp Disaster Med. 2015 Aug;30(4):385-9. doi: 10.1017/S1049023X15004793. Epub 2015 Jun 10.

PMID:
26061280
5.

Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administration.

Kerr D, Dietze P, Kelly AM, Jolley D.

J Urban Health. 2008 May;85(3):352-60. doi: 10.1007/s11524-008-9273-z. Epub 2008 Mar 18.

6.

Intranasal naloxone administration for treatment of opioid overdose.

Robinson A, Wermeling DP.

Am J Health Syst Pharm. 2014 Dec 15;71(24):2129-35. doi: 10.2146/ajhp130798. Review.

PMID:
25465584
7.

Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.

Lenton S, Dietze P, Olsen A, Wiggins N, McDonald D, Fowlie C.

Drug Alcohol Rev. 2015 Jul;34(4):404-11. doi: 10.1111/dar.12198. Epub 2014 Oct 1.

PMID:
25272281
8.

Two cases of intranasal naloxone self-administration in opioid overdose.

Green TC, Ray M, Bowman SE, McKenzie M, Rich JD.

Subst Abus. 2014;35(2):129-32. doi: 10.1080/08897077.2013.825691.

9.

Can nebulized naloxone be used safely and effectively by emergency medical services for suspected opioid overdose?

Weber JM, Tataris KL, Hoffman JD, Aks SE, Mycyk MB.

Prehosp Emerg Care. 2012 Apr-Jun;16(2):289-92. doi: 10.3109/10903127.2011.640763. Epub 2011 Dec 22.

PMID:
22191727
10.

Safety of enteral naloxone for the reversal of opiate-induced constipation in the intensive care unit.

Arpino PA, Thompson BT.

J Clin Pharm Ther. 2009 Apr;34(2):171-5. doi: 10.1111/j.1365-2710.2008.00982.x.

PMID:
19250137
11.
12.

EMS runs for suspected opioid overdose: implications for surveillance and prevention.

Knowlton A, Weir BW, Hazzard F, Olsen Y, McWilliams J, Fields J, Gaasch W.

Prehosp Emerg Care. 2013 Jul-Sep;17(3):317-29. doi: 10.3109/10903127.2013.792888.

13.

Intranasal naloxone for the treatment of suspected heroin overdose.

Kerr D, Dietze P, Kelly AM.

Addiction. 2008 Mar;103(3):379-86. doi: 10.1111/j.1360-0443.2007.02097.x. Review.

PMID:
18269360
14.

Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.

Yokell MA, Zaller ND, Green TC, McKenzie M, Rich JD.

J Opioid Manag. 2012 Jan-Feb;8(1):63-6.

15.

Naloxone's basic benefit. Why the overdose-reversal drug is worth expanding beyond just ALS providers.

Furlano E.

EMS World. 2014 Oct;43(10):28-30, 32-4. No abstract available.

PMID:
25812292
16.

Naloxone (Narcan) nasal spray for opioid overdose.

[No authors listed]

Med Lett Drugs Ther. 2016 Jan 4;58(1485):1-2. No abstract available.

PMID:
26714239
17.

Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting.

Barton ED, Colwell CB, Wolfe T, Fosnocht D, Gravitz C, Bryan T, Dunn W, Benson J, Bailey J.

J Emerg Med. 2005 Oct;29(3):265-71.

PMID:
16183444
18.

Heroin overdose resuscitation with naloxone: patient uses own prescribed supply to save the life of a peer.

Winston I, McDonald R, Tas B, Strang J.

BMJ Case Rep. 2015 Sep 14;2015. pii: bcr2015210391. doi: 10.1136/bcr-2015-210391.

PMID:
26370638
19.

The benefits and potential drawbacks in the approval of EVZIO for lay reversal of opioid overdose.

Beletsky L.

Am J Prev Med. 2015 Mar;48(3):357-9. doi: 10.1016/j.amepre.2014.09.011. Epub 2014 Dec 26. Review. No abstract available.

20.

Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose.

Doe-Simkins M, Walley AY, Epstein A, Moyer P.

Am J Public Health. 2009 May;99(5):788-91. doi: 10.2105/AJPH.2008.146647.

Items per page

Supplemental Content

Write to the Help Desk